Porvair plc (LON:PRV - Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as GBX 796 ($10.58) and last traded at GBX 772 ($10.26), with a volume of 73317 shares traded. The stock had previously closed at GBX 772 ($10.26).
Analyst Upgrades and Downgrades
Separately, Shore Capital reissued a "hold" rating on shares of Porvair in a research report on Tuesday, April 15th.
Get Our Latest Analysis on PRV
Porvair Stock Performance
The stock has a market capitalization of £353.23 million, a P/E ratio of 22.89 and a beta of 0.76. The company has a current ratio of 1.83, a quick ratio of 1.22 and a debt-to-equity ratio of 19.67. The company has a 50-day moving average price of GBX 699.26 and a 200 day moving average price of GBX 688.80.
Porvair (LON:PRV - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported GBX 38.60 ($0.51) EPS for the quarter. Porvair had a return on equity of 10.75% and a net margin of 8.57%. On average, research analysts forecast that Porvair plc will post 39.0358613 earnings per share for the current fiscal year.
Insider Buying and Selling at Porvair
In other news, insider Ben Stocks sold 70,000 shares of Porvair stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of GBX 716 ($9.51), for a total transaction of £501,200 ($665,958.01). 21.55% of the stock is currently owned by company insiders.
About Porvair
(
Get Free Report)
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Porvair, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Porvair wasn't on the list.
While Porvair currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
